Candel Therapeutics Statistics Share Statistics Candel Therapeutics has 53.32M
shares outstanding. The number of shares has increased by 66.2%
in one year.
Shares Outstanding 53.32M Shares Change (YoY) 66.2% Shares Change (QoQ) 12.89% Owned by Institutions (%) 41.98% Shares Floating 36.7M Failed to Deliver (FTD) Shares 14,456 FTD / Avg. Volume 1.53%
Short Selling Information The latest short interest is 6.56M, so 13.08% of the outstanding
shares have been sold short.
Short Interest 6.56M Short % of Shares Out 13.08% Short % of Float 16.95% Short Ratio (days to cover) 5.83
Valuation Ratios The PE ratio is -4.98 and the forward
PE ratio is -8.86.
Candel Therapeutics's PEG ratio is
-0.15.
PE Ratio -4.98 Forward PE -8.86 PS Ratio 0 Forward PS 3.6 PB Ratio 4.15 P/FCF Ratio -10.17 PEG Ratio -0.15
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Candel Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.77,
with a Debt / Equity ratio of 0.2.
Current Ratio 2.77 Quick Ratio 2.77 Debt / Equity 0.2 Debt / EBITDA -0.26 Debt / FCF -0.5 Interest Coverage -15.97
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.45M Employee Count 38 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 11.29% in the
last 52 weeks. The beta is -0.88, so Candel Therapeutics's
price volatility has been lower than the market average.
Beta -0.88 52-Week Price Change 11.29% 50-Day Moving Average 5.81 200-Day Moving Average 6.37 Relative Strength Index (RSI) 46.67 Average Volume (20 Days) 942,561
Income Statement
Revenue n/a Gross Profit n/a Operating Income -33.37M Net Income -55.18M EBITDA -52.1M EBIT -53.09M Earnings Per Share (EPS) -1.74
Full Income Statement Balance Sheet The company has 102.65M in cash and 13.47M in
debt, giving a net cash position of 89.18M.
Cash & Cash Equivalents 102.65M Total Debt 13.47M Net Cash 89.18M Retained Earnings -192.21M Total Assets 95.91M Working Capital 73.08M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -27.02M
and capital expenditures -16K, giving a free cash flow of -27.04M.
Operating Cash Flow -27.02M Capital Expenditures -16K Free Cash Flow -27.04M FCF Per Share -0.85
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
